RT Journal Article
SR Electronic
T1 A collaborative online AI engine for CT-based COVID-19 diagnosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.10.20096073
DO 10.1101/2020.05.10.20096073
A1 Xu, Yongchao
A1 Ma, Liya
A1 Yang, Fan
A1 Chen, Yanyan
A1 Ma, Ke
A1 Yang, Jiehua
A1 Yang, Xian
A1 Chen, Yaobing
A1 Shu, Chang
A1 Fan, Ziwei
A1 Gan, Jiefeng
A1 Zou, Xinyu
A1 Huang, Renhao
A1 Zhang, Changzheng
A1 Liu, Xiaowu
A1 Tu, Dandan
A1 Xu, Chuou
A1 Zhang, Wenqing
A1 Yang, Dehua
A1 Wang, Ming-Wei
A1 Wang, Xi
A1 Xie, Xiaoliang
A1 Leng, Hongxiang
A1 Holalkere, Nagaraj
A1 Halin, Neil J.
A1 Kamel, Ihab Roushdy
A1 Wu, Jia
A1 Peng, Xuehua
A1 Wang, Xiang
A1 Shao, Jianbo
A1 Mongkolwat, Pattanasak
A1 Zhang, Jianjun
A1 Rubin, Daniel L.
A1 Wang, Guoping
A1 Zheng, Chuangsheng
A1 Li, Zhen
A1 Bai, Xiang
A1 Xia, Tian
YR 2020
UL http://medrxiv.org/content/early/2020/05/19/2020.05.10.20096073.abstract
AB Artificial intelligence can potentially provide a substantial role in streamlining chest computed tomography (CT) diagnosis of COVID-19 patients. However, several critical hurdles have impeded the development of robust AI model, which include deficiency, isolation, and heterogeneity of CT data generated from diverse institutions. These bring about lack of generalization of AI model and therefore prevent it from applications in clinical practices. To overcome this, we proposed a federated learning-based Unified CT-COVID AI Diagnostic Initiative (UCADI, http://www.ai-ct-covid.team/), a decentralized architecture where the AI model is distributed to and executed at each host institution with the data sources or client ends for training and inferencing without sharing individual patient data. Specifically, we firstly developed an initial AI CT model based on data collected from three Tongji hospitals in Wuhan. After model evaluation, we found that the initial model can identify COVID from Tongji CT test data at near radiologist-level (97.5% sensitivity) but performed worse when it was tested on COVID cases from Wuhan Union Hospital (72% sensitivity), indicating a lack of model generalization. Next, we used the publicly available UCADI framework to build a federated model which integrated COVID CT cases from the Tongji hospitals and Wuhan Union hospital (WU) without transferring the WU data. The federated model not only performed similarly on Tongji test data but improved the detection sensitivity (98%) on WU test cases. The UCADI framework will allow participants worldwide to use and contribute to the model, to deliver a real-world, globally built and validated clinic CT-COVID AI tool. This effort directly supports the United Nations Sustainable Development Goals’ number 3, Good Health and Well-Being, and allows sharing and transferring of knowledge to fight this devastating disease around the world.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialno clinical trialFunding StatementThis study was supported by HUST COVID-19 Rapid Response Call (No. 2020kfyXGYJ031, No. 2020kfyXGYJ093, No. 2020kfyXGYJ094) and the National Natural Science Foundation of China (61703171 and 81771801). This work was also supported in part by a grant from the National Cancer Institute, National Institutes of Health, U01CA242879, and Thammasat University Research fund under the NRCT, Contract No. 25/2561, for the project of ‘Digital platform for sustainable digital economy development’, based on the RUN Digital Cluster collaboration scheme.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data used for developing the initial model and federated models during the current study are not publicly available. We claimed that this study was approved by the Ethics Committee Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology to access this dataset for our research purpose. http://www.ai-ct-covid.team/